-
RNAseq samples of patients with anti-PD-1 resistant HNSCC from a non-randomized, open-label phase 1b clinical trial
Study
EGAS50000000728
-
WES samples of patients with anti-PD-1 resistant HNSCC from a non-randomized, open-label phase 1b clinical trial
Study
EGAS50000000729
-
RNA-seq of murine osteosarcoma cell line genetically modified for CYR61
Study
EGAS50000000526
-
Target sequencing for 53 synovial sarcoma patients
Study
EGAS50000000522
-
Whole exome sequencing data of patients with resectable esophageal adenocarcinoma treated with neoadjuvant atezolizumab and chemoradiation (PERFECT)
Study
EGAS00001006504
-
Whole Exome Sequencing (WES) data of PERFECT trial
Dataset
EGAD50000001153
-
"IL-17A-Producing ILC3s and Duodenal Adenoma in FAP"
Dac
EGAC00001003301
-
Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma.
Study
EGAS50000000371
-
Immune Determinants of Resistance to PD-1 Blockade in Renal Cell Carcinoma
Study
phs003618
-
metastatic uveal melanoma tumour biopsies (n=35)
Study
EGAS50000000836